Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$8.50
+2.04%
Mkt Cap $425.11M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$24.50
Range $19.00 – $30.00
Implied Upside
+188.2%
Consensus $24.50 vs current $8.50
NASDAQ·Healthcare·Biotechnology
$8.50
+2.04%
Mkt Cap $425.11M
No recent rating data.
Price Target (15 analysts)
$24.50
Range $19.00 – $30.00
+188.2%
Consensus $24.50 vs current $8.50